# A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies

> **NCT01321489** · PHASE3 · UNKNOWN · sponsor: **Laboratório Teuto Brasileiro S/A** · enrollment: 78 (estimated)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Sildenafil Citrate 20mg Tablet Sublingual
- **DRUG:** Viagra ® 50mg tablet Coated

## Key facts

- **NCT ID:** NCT01321489
- **Lead sponsor:** Laboratório Teuto Brasileiro S/A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2011-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01321489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01321489, "A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01321489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*